Section: Pet Parasites

Hepatozoon canis: Tick-Borne Protozoan in Dogs – Blood Smear Diagnosis and Clinical Management

Etiology and Taxonomy

Hepatozoon canis is an apicomplexan protozoan parasite belonging to the family Hepatozoidae. Unlike most tick-borne pathogens that are transmitted via tick saliva during feeding, H. canis is transmitted to dogs through the ingestion of ticks containing mature oocysts. The definitive host is the ixodid tick, primarily Rhipicephalus sanguineus (the brown dog tick), in which sexual reproduction and oocyst formation occur. Dogs serve as intermediate hosts, harboring the asexual stages (meronts and gamonts) in various tissues, particularly bone marrow, spleen, lymph nodes, and skeletal muscle. The parasite was first described in dogs in 1905 and has since been recognized as a cause of canine hepatozoonosis, a disease with a wide geographic distribution.

Epidemiology and Geographic Distribution

Canine hepatozoonosis has been reported across tropical, subtropical, and temperate regions worldwide. High prevalence rates are documented in parts of Africa, Asia, the Middle East, southern Europe, and the Americas. In a survey of stray dogs in northeastern Iran, Barati and Razmi [1] reported a prevalence of 12.5% using microscopic examination and 18.8% using PCR, indicating substantial subclinical carriage. Similarly, Bhagwan et al. [2] detected H. canis in dogs from Haryana, India, using molecular and microscopic methods, with co-infections with other haemoprotozoa being common. In southeastern Bahia, Brazil, Harvey et al. [3] found a prevalence of 8.3% in dogs, highlighting the parasite's endemicity in South America. A notable case from Australia reported by Greay et al. [4] described an imported dog diagnosed with H. canis, raising questions about the country's status as free from this pathogen. The first clinical case in Ukraine was documented by Galat et al. [5], expanding the known range into Eastern Europe. The distribution of H. canis closely mirrors that of its tick vector R. sanguineus, and environmental factors such as temperature and humidity influence transmission dynamics.

Transmission: Tick Ingestion as the Key Route

The unique transmission mechanism of H. canis distinguishes it from other tick-borne pathogens. Dogs acquire infection by ingesting ticks that contain mature oocysts. This typically occurs during grooming or when consuming tick-infested prey. After ingestion, sporozoites are released from oocysts in the canine gastrointestinal tract, penetrate the intestinal wall, and enter the bloodstream. They then invade mononuclear phagocytes and undergo merogony in tissues such as bone marrow, spleen, and lymph nodes. The prepatent period ranges from 2 to 4 weeks. Horizontal transmission via tick ingestion is the primary route; vertical transmission (transplacental) has been suggested but is not well documented. The role of tick ingestion in transmission is critical for understanding prevention strategies, as acaricide treatment alone may not be sufficient if dogs ingest ticks.

Clinical Signs and Pathogenesis

Clinical manifestations of canine hepatozoonosis vary from subclinical infection to severe, life-threatening disease. Factors influencing severity include the parasite burden, host immune status, age, and concurrent infections. Young dogs and those with immunosuppression are more susceptible to severe disease.

Common clinical signs include:

  • Fever (often intermittent)
  • Lethargy and depression
  • Anorexia and weight loss
  • Muscle pain and stiffness (myositis)
  • Lymphadenomegaly
  • Splenomegaly
  • Pale mucous membranes (anemia)
  • Ocular discharge and uveitis
  • Neurologic signs (rare, associated with meningoencephalitis)

In chronic cases, dogs may develop a characteristic "hunched" posture due to periosteal bone proliferation, particularly along the long bones and vertebrae. This osteomyelitis-like reaction is a hallmark of severe hepatozoonosis. The pathogenesis involves a marked inflammatory response to the presence of meronts and gamonts in tissues. Kiral et al. [6] demonstrated that dogs with H. canis infection respond to oxidative stress by increasing production of glutathione and nitric oxide, indicating a host antioxidant defense mechanism that may influence disease progression.

Pathology and Laboratory Findings

Gross pathological findings include splenomegaly, lymphadenopathy, and pale bone marrow. Histologically, meronts (schizonts) are observed in the bone marrow, spleen, lymph nodes, and skeletal muscle. Gamonts are found within neutrophils and monocytes in peripheral blood. Periosteal new bone formation is evident on radiographs in chronic cases.

Hematological abnormalities commonly include:

  • Normocytic, normochromic anemia
  • Leukocytosis (often marked neutrophilia)
  • Thrombocytopenia (less consistent than in ehrlichiosis)
  • Elevated acute phase proteins

Biochemical changes may include increased alkaline phosphatase, creatine kinase (due to myositis), and globulins. Co-infections with other tick-borne agents such as Ehrlichia canis, Anaplasma platys, and Babesia vogeli are frequent and can complicate the clinical picture [7]. For a broader context on tick-borne diseases in dogs, refer to the article Tick-Borne Diseases in Dogs: Comprehensive Review of Common Pathogens, Clinical Syndromes, and Management.

Diagnosis: Blood Smear and Molecular Methods

Blood Smear Diagnosis

Microscopic examination of Giemsa-stained peripheral blood smears remains a cornerstone of diagnosis. Hepatozoon canis gamonts are elongated, ellipsoid structures measuring approximately 8–11 µm by 3–5 µm, with a pale blue cytoplasm and a central, band-like nucleus. They are typically found within neutrophils, but may also be seen in monocytes. The presence of gamonts in blood smears is diagnostic, but sensitivity is limited, especially in chronic or low-parasitemia infections. Otranto et al. [8] compared cytology and PCR in young dogs and found that PCR was more sensitive, detecting infections missed by blood smear examination. In a survey by Karagenc et al. [9] along the Aegean coast of Turkey, blood smear examination yielded a prevalence of 10.5%, while PCR detected 19.7%, confirming the superior sensitivity of molecular methods.

Molecular Detection

PCR-based assays targeting the 18S rRNA gene are the gold standard for sensitive and specific detection of H. canis. These assays can differentiate H. canis from other apicomplexan parasites and are particularly useful in cases of low parasitemia or when co-infections are suspected. Kaewkong et al. [10] developed a high-throughput pyrosequencing method for differential detection of Babesia vogeli, H. canis, Ehrlichia canis, and Anaplasma platys in canine blood samples, demonstrating the utility of multiplex molecular approaches. Real-time PCR and conventional PCR are widely used in diagnostic laboratories. For a discussion of related diagnostic technologies, see Point-of-Care Molecular Diagnostics for Feline Upper Respiratory Pathogens, though the principles of PCR apply broadly.

Serology

Serological tests, including indirect fluorescent antibody tests (IFAT) and enzyme-linked immunosorbent assays (ELISA), have been developed for H. canis. Baneth et al. [11] characterized the antibody response in experimentally infected dogs, showing that IgG antibodies appear 2–3 weeks post-infection and persist for months. However, serology cannot distinguish between current and past infection, and cross-reactivity with other apicomplexans may occur. Serology is more useful for epidemiological surveys than for individual clinical diagnosis.

Diagnostic Decision Workflow

The following Mermaid diagram outlines a diagnostic workflow for suspected canine hepatozoonosis.

flowchart TD
    A[Clinical suspicion: fever, lethargy, myalgia, tick exposure], > B{Blood smear examination}
    B, >|Gamonts present| C[Confirm diagnosis: Hepatozoon canis]
    B, >|Gamonts absent| D[Perform PCR (18S rRNA)]
    D, >|Positive| C
    D, >|Negative| E[Consider other tick-borne diseases]
    E, > F[Test for Ehrlichia canis, Anaplasma spp., Babesia spp.]
    F, > G[If negative, reassess clinical signs and consider serology]
    C, > H[Assess severity: CBC, biochemistry, radiographs for periosteal lesions]
    H, > I[Initiate treatment and supportive care]

Treatment and Clinical Management

Treatment of canine hepatozoonosis is challenging, as no drug reliably eliminates the parasite. The goal is to reduce parasitemia and alleviate clinical signs. The most commonly used therapeutic regimen is a combination of:

  • Imidocarb dipropionate (5–6 mg/kg subcutaneously or intramuscularly, repeated once after 14 days). This drug has activity against H. canis but may not achieve complete clearance.
  • Doxycycline (10 mg/kg orally once daily for 28 days) is often added to address potential co-infections with Ehrlichia canis or Anaplasma spp.
  • Toltrazuril (10 mg/kg orally once daily for 5 days) has been used with variable success.
  • Clindamycin (10–15 mg/kg orally twice daily for 28 days) may be considered for its antiprotozoal effects.

Supportive care is critical and includes:

  • Fluid therapy for dehydrated or anorexic patients
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation (e.g., carprofen, meloxicam)
  • Corticosteroids (e.g., prednisolone) in cases of severe immune-mediated inflammation, but with caution due to potential immunosuppression
  • Nutritional support via appetite stimulants or feeding tubes if necessary
  • Blood transfusion in cases of severe anemia

Prognosis depends on the severity of disease and presence of co-infections. Mild cases often respond well to therapy, but relapses can occur. Chronic cases with extensive periosteal bone proliferation have a guarded prognosis. Long-term monitoring with periodic blood smears and PCR is recommended to detect recrudescence.

Prevention and Control

Prevention of H. canis infection centers on reducing tick exposure and preventing tick ingestion. Key strategies include:

  • Acaricide application: Use of topical or oral acaricides (e.g., fipronil, permethrin, isoxazolines) to kill ticks before they can be ingested. However, acaricides do not prevent ingestion of dead ticks; therefore, environmental tick control is also important.
  • Environmental management: Reducing tick habitats by keeping grass short, removing leaf litter, and using tick control products in kennels and yards.
  • Grooming and inspection: Regular grooming to remove and dispose of ticks before ingestion occurs.
  • Avoidance of raw prey: Preventing dogs from consuming tick-infested prey animals (e.g., rodents, rabbits) in endemic areas.
  • Quarantine and screening: Screening dogs imported from endemic regions using PCR and blood smear examination to prevent introduction of the parasite into non-endemic areas, as highlighted by Greay et al. [4].

For a broader perspective on tick-borne disease prevention, see Dog Tick-Borne Illness Treatment: A Comprehensive Guide to Ehrlichiosis, Anaplasmosis, and Lyme Disease.

Co-Infections and Differential Diagnosis

Co-infections with other tick-borne agents are common due to shared vector ecology. Abd Rani et al. [7] surveyed canine tick-borne diseases in India and found frequent co-infections of H. canis with Ehrlichia canis, Babesia vogeli, and Anaplasma platys. These co-infections can exacerbate clinical signs and complicate diagnosis. Differential diagnoses for canine hepatozoonosis include:

A thorough diagnostic workup including blood smear, PCR panel, and serology is essential to differentiate these conditions.

Conclusion

Hepatozoon canis is a unique tick-borne protozoan that requires ingestion of the tick vector for transmission. Blood smear diagnosis remains a valuable first-line tool, but molecular methods such as PCR offer superior sensitivity and are essential for confirming infection in low-parasitemia cases. Clinical management involves antiprotozoal therapy and supportive care, with a guarded prognosis in severe cases. Prevention relies on rigorous tick control and preventing tick ingestion. As the geographic range of H. canis expands, awareness among veterinarians and pet owners is critical for timely diagnosis and management.

References

[1] Barati A, Razmi GR. A Parasitologic and Molecular Survey of Hepatozoon canis Infection In Stray Dogs In Northeastern Iran. J Parasitol. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29664327/

[2] Bhagwan J, Singh Y, Jhambh R, et al. Molecular and microscopic detection of haemoprotozoan diseases in dogs from Haryana, India. Parasitol Res. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39422774/

[3] Harvey TV, Guedes PE, Oliveira TN, et al. Canine hepatozoonosis in southeastern Bahia, Brazil. Genet Mol Res. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27706560/

[4] Greay TL, Barbosa AD, Rees RL, et al. An Australian dog diagnosed with an exotic tick-borne infection: should Australia still be considered free from Hepatozoon canis? Int J Parasitol. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30059690/

[5] Galat M, Gliga D, Storozhuk V, et al. First case of clinical canine hepatozoonosis in Ukraine. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40683456/

[6] Kiral F, Karagenc T, Pasa S, et al. Dogs with Hepatozoon canis respond to the oxidative stress by increased production of glutathione and nitric oxide. Vet Parasitol. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/15936891/

[7] Abd Rani PA, Irwin PJ, Coleman GT, et al. A survey of canine tick-borne diseases in India. Parasit Vectors. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21771313/

[8] Otranto D, Dantas-Torres F, Weigl S, et al. Diagnosis of Hepatozoon canis in young dogs by cytology and PCR. Parasit Vectors. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21489247/

[9] Karagenc TI, Pasa S, Kirli G, et al. A parasitological, molecular and serological survey of Hepatozoon canis infection in dogs around the Aegean coast of Turkey. Vet Parasitol. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16229952/

[10] Kaewkong W, Intapan PM, Sanpool O, et al. High throughput pyrosequencing technology for molecular differential detection of Babesia vogeli, Hepatozoon canis, Ehrlichia canis and Anaplasma platys in canine blood samples. Ticks Tick Borne Dis. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/24704311/

[11] Baneth G, Shkap V, Samish M, et al. Antibody response to Hepatozoon canis in experimentally infected dogs. Vet Parasitol. 1998. URL: https://pubmed.ncbi.nlm.nih.gov/9561714/